If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,344.00
Ask: 12,346.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,268.00
High: 12,388.00
Low: 12,256.00
Prev. Close: 12,264.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EC chief warns Astra must honour contract before exporting doses

Fri, 26th Mar 2021 05:59

(Alliance News) - The European Commission president has warned AstraZeneca PLC that it must "honour" its vaccine contract with the bloc before exporting doses elsewhere in the world.

Ursula von der Leyen urged "transparency" from other countries, but did not confirm if the EU would bring in tougher export restrictions on coronavirus jabs, amid a row over supplies with the British-Swedish pharmaceutical giant.

However, she acknowledged that worldwide supply chains needed to remain "intact" for vaccine production, while some European leaders appeared optimistic that the UK and EU could soon resolve their dispute over supplies.

Elsewhere, UK Prime Minister Boris Johnson sought to calm fears over the possible introduction of coronavirus certificates after publicans criticised his suggestion that it may be up to landlords to decide to request proof of vaccination in venues.

Just days after the prime minister flagged tougher measures to prevent Covid-19 variants being transmitted from Europe, the Telegraph reports the government is planning to implement a mass testing regime for lorry drivers arriving in the UK.

Earlier, addressing a Brussels press conference following a meeting of the European Council on Thursday, von der Leyen said she had "no knowledge" of the UK exporting jabs, while 77 million doses had been exported to 33 countries by the EU so far.

It came after the European Commission set out a tougher regime to stem supplies of jabs to nations faring better in the pandemic as the bloc's states faced a third wave of cases.

von der Leyen told reporters: "Companies have to honour their contract to the EU before they export to other regions in the world. This is of course the case with AstraZeneca.

"I think it is clear that the company [AstraZeneca] has to catch up and honour the contract it has with the EU member states before it can engage again in exporting vaccines."

She added: "We have worldwide supply chains that have to be intact and it is of the utmost importance that we get back to an attitude of openness."

Asked about how many vaccines the UK had exported, von der Leyen told reporters: "I have no knowledge so far of UK exports, perhaps I am mistaken and waiting for their transparency."

Following the summit, Belgian Prime Minister Alexander de Croo said that he believed the EU's dispute with the UK over vaccine supplies "can be resolved" as he referred to a phone call with Johnson last week.

"We think that the discussion we have with the UK can be resolved based on good agreements," de Croo told a Brussels press conference.

Striking a similar tone, Dutch Prime Minister Mark Rutte said that he was "cautiously optimistic" that divisions between the UK and the EU could be resolved.

"I think that on Saturday or soon after, they could come to an agreement which would be very helpful because we are friends, the UK and the rest of Europe, and we need each other," he told reporters.

But leaders appeared to be divided on the issue following the summit, with French president Emmanuel Macron insisting that the EU is "no longer naive" with its export controls tool.

It came after Johnson acknowledged the "moral complexities" around a domestic coronavirus certificate and suggested that it might only be possible to introduce one after all adults had been offered a vaccine at the end of July.

The government will say more on the possible use of Covid status certificates in early April, which could be based on whether people have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after the PM's earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry.

A mobile phone app which features a scannable QR code could be used to provide a virtual coronavirus certificate for entrance into pubs, clubs and restaurants, according to the Daily Mail.

Measures to implement Johnson's "road map" out of lockdown, which will see England's restrictions eased in a series of stages over the coming months, were passed without a vote.

But a series of Tory MPs refused to back a six-month extension to emergency powers contained in the Coronavirus Act after Health Secretary Matt Hancock was unable to say whether they would definitely expire after that.

Some 76 MPs voted to oppose the extension of the laws, although the measure passed with a majority of 408.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.